0001171843-17-006332.txt : 20171026 0001171843-17-006332.hdr.sgml : 20171026 20171026160650 ACCESSION NUMBER: 0001171843-17-006332 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171024 FILED AS OF DATE: 20171026 DATE AS OF CHANGE: 20171026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERWOOD CHARLES H CENTRAL INDEX KEY: 0001244298 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 171156372 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2017-10-24 0 0000898437 Anika Therapeutics, Inc. ANIK 0001244298 SHERWOOD CHARLES H 32 WIGGINS AVENUE BEDFORD MA 01730 1 1 0 0 CEO and Director Common Stock 2017-10-24 4 S 0 3278 60.04 D 132791 D On October 24, 2017, pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 on February 21, 2017, Dr. Sherwood sold 3,278 shares in multiple trades ranging from $60.00 to $60.10. The price reported above reflects the weighted average sale price. Dr. Sherwood undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected. /s/ Charles H. Sherwood, Ph.D. 2017-10-26